Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Aytu BioPharma, Inc. (NASDAQ: AYTU)
AYTU Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
25%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
122.10%
AYTU Stock Analysis
AYTU
PE Ratio:
AYTU
PEG Ratio:
Not Available
AYTU
Forward EPS Growth (12 month):
0.00%
AYTU
PS Ratio:
0.3
AYTU
PSG Ratio:
AYTU
Forward Revenue Growth (12 month):
31.40%
AYTU Articles
No data was found